Robert Young Kim - Net Worth and Insider Trading
Robert Young Kim Net Worth
The estimated net worth of Robert Young Kim is at least $6,060 dollars as of 2024-12-26. Robert Young Kim is the Chief Medical Officer of 4D Molecular Therapeutics Inc and owns about 1,043 shares of 4D Molecular Therapeutics Inc (FDMT) stock worth over $6,060. Details can be seen in Robert Young Kim's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Young Kim has not made any transactions after 2024-02-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Young Kim
Robert Young Kim Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Young Kim owns 1 companies in total, including 4D Molecular Therapeutics Inc (FDMT) .
Click here to see the complete history of Robert Young Kim’s form 4 insider trades.
Insider Ownership Summary of Robert Young Kim
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FDMT | 4D Molecular Therapeutics Inc | 2024-02-05 | Chief Medical Officer |
Robert Young Kim Latest Holdings Summary
Robert Young Kim currently owns a total of 1 stock. Robert Young Kim owns 1,043 shares of 4D Molecular Therapeutics Inc (FDMT) as of February 5, 2024, with a value of $6,060.
Latest Holdings of Robert Young Kim
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FDMT | 4D Molecular Therapeutics Inc | 2024-02-05 | 1,043 | 5.81 | 6,060 |
Holding Weightings of Robert Young Kim
Robert Young Kim Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Young Kim has made a total of 1 transactions in 4D Molecular Therapeutics Inc (FDMT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in 4D Molecular Therapeutics Inc is the sale of 24,552 shares on February 5, 2024, which brought Robert Young Kim around $737,788.
Insider Trading History of Robert Young Kim
- 1
Robert Young Kim Trading Performance
Robert Young Kim Ownership Network
Robert Young Kim Owned Company Details
What does 4D Molecular Therapeutics Inc do?
Who are the key executives at 4D Molecular Therapeutics Inc?
Robert Young Kim is the Chief Medical Officer of 4D Molecular Therapeutics Inc. Other key executives at 4D Molecular Therapeutics Inc include Chief Legal and HR Officer Scott Bizily , director & Chief Executive Officer David Kirn , and 10 percent owner Viking Global Investors Lp .
4D Molecular Therapeutics Inc (FDMT) Insider Trades Summary
Over the past 18 months, Robert Young Kim made 1 insider transaction in 4D Molecular Therapeutics Inc (FDMT) with a net sale of 24,552. Other recent insider transactions involving 4D Molecular Therapeutics Inc (FDMT) include a net sale of 39,883 shares made by Scott Bizily , a net sale of 225,853 shares made by David Kirn , and a net sale of 540,000 shares made by Viking Global Investors Lp .
In summary, during the past 3 months, insiders sold 0 shares of 4D Molecular Therapeutics Inc (FDMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 830,288 shares of 4D Molecular Therapeutics Inc (FDMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 830,288 shares.
4D Molecular Therapeutics Inc (FDMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
4D Molecular Therapeutics Inc Insider Transactions
Robert Young Kim Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Young Kim. You might contact Robert Young Kim via mailing address: C/o 4d Molecular Therapeutics, Inc., 5858 Horton Street #455, Emeryville Ca 94608.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
